Piramal Pharma Ltd

Common Name

Piramal Pharma

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

5,476

Ticker

PPLPHARMA

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

www.piramal.com

Description

Piramal Pharma Ltd. is a leading pharmaceutical company engaged in the development, manufacture, and distribution of a wide range of pharmaceutical products. The company plays a crucial role in the he... Show more

Financial Statements of Piramal Pharma

Below are the financial statements of Piramal Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of INR	2025	2024
Non-current assets	—	—
Property, plant & equipment	41.76^a	38.73^a
Capital work in progress	4.89^a	5.66^a
Goodwill	11.48^a	11.23^a
Intangible asset	24.51^a	26.17^a
Intangible assets under development	4.88^a	5.5^a
Right of use assets	3.58^a	3.78^a
Financial assets	—	—
Investments - Investments accounted for using the equity method	2.27^a	2.05^a
Investments - Other investments	0.44^a	0.35^a
Other financial assets	0.21^a	0.21^a
Income tax assets (net)	0.23^a	0.37^a
Deferred tax assets (net)	3.93^a	3.87^a
Other non-current assets	0.62^a	0.57^a
Total non-current assets	98.81^a	98.47^a
Current assets	—	—
Inventories	23.13^a	21.76^a
Financial assets	—	—
Investments	0.2^a	1.45^a
Trade receivables	23.5^a	21.34^a
Cash & cash equivalents	3.69^a	3.57^a
Bank balances other than	1.32^a	1.26^a
Other financial assets	0.56^a	0.16^a
Income tax asset (net)	0.06^a	0.01^a
Other current assets	5.52^a	5.1^a
Total current assets	57.97^a	54.64^a
Total assets	156.78^a	153.12^a
Equity	—	—
Equity share capital	13.24^a	13.23^a
Other equity	68.01^a	65.88^a
Total equity	81.25^a	79.11^a
Financial liabilities	—	—
Borrowings	32.14^a	24.84^a
Lease liabilities	0.99^a	1.18^a
Non-current liabilities	—	—
Provisions	0.49^a	0.32^a
Deferred tax liabilities (net)	2.48^a	2.29^a
Other non-current liabilities	1.76^a	1.68^a
Total non-current liabilities	37.86^a	30.31^a
Financial liabilities	—	—
Borrowings	15.06^a	20.75^a
Lease liabilities	0.37^a	0.33^a
Trade payables	—	—
Total outstanding dues of micro enterprises and small enterprises	0.42^a	0.46^a
Total outstanding dues of creditors other than micro enterprises and small enterprises	14.92^a	14.92^a
Other financial liabilities	3.63^a	2.51^a
Current liabilities	—	—
Other current liabilities	2.74^a	3.87^a
Provisions	0.43^a	0.44^a
Current tax liabilities (net)	0.1^a	0.4^a
Total current liabilities	37.66^a	43.69^a
Total liabilities	75.52^a	74^a
Total equity & liabilities	156.78^a	153.12^a

Verified Sources Behind Piramal Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Piramal Pharma’s data sources below and access millions more through our Disclosure Search.

a. Piramal Pharma's Annual Report 2025

Trace every data point back to Piramal Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Piramal Pharma Ltd

Financial Statements of Piramal Pharma

Verified Sources Behind Piramal Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Natco Pharma Ltd

IPCA Laboratories Ltd

J B Chemicals and Pharmaceuticals Ltd

Abbott India Ltd

Gland Pharma Ltd

Ajanta Pharma Ltd